Custom Search by Tirgan.com

Home    Content    services

Doxil

Doxil is a rather new form of the old Doxorubicin, however combined with lipid (fat) molecules, also known as Liposomal Doxorubicin. Doxil seems to be effective in a variety of tumors, however it has been approved by FDA for treatment of AIDS related Kaposi’s Sarcoma. This drug is still under investigation to determine its efficacy against other cancers. It seems that Doxil should be effective against most of same cancers that are sensitive to Doxorubicin.

The type and extent of a cancer will determine the method and schedule of administration of this drug. This decision is made by the medical oncologist.

Side effects:

The degree and severity of the side effects depend on the amount and schedule of the administration of Doxil. Doxil does not cause nausea or vomiting. It can cause skin reactions. The important issue to prove is whether Doxil has less Cardiac Toxicity (Heart problems) as compared to Doxorubicin.

It is imperative that patients communicate any side effects or problems to his/her medical oncologist.